Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Tops & Flops Stocks

Security Change (%) 1w 1m ▼ 1y YTD 3y 5y
Catalyst Pharmaceutical Partners Inc 3.730% -3.012% -4.200% -13.413% -11.937% 252.343% 445.654%
Medpace Holdings Inc -0.250% -3.454% -4.249% 89.391% 28.327% 165.147% -
BioMarin Pharmaceutical Inc. -0.450% 1.507% -4.454% -11.967% -12.509% 20.225% 4.632%
Voyager Therapeutics Inc -2.070% 9.848% -4.548% 5.629% 0.314% 125.410% -
AbbVie Inc. -0.230% -2.034% -4.601% 11.403% 6.552% 56.939% 112.771%
Rhythm Pharmaceuticals -2.210% 0.000% -4.688% 140.789% -14.085% - -
IQVIA Holdings Inc. -0.800% -3.503% -4.717% 22.885% 1.241% 10.096% -
Exelixis Inc. 1.250% -7.458% -4.728% 17.562% -6.993% -1.405% 10.382%
Collegium Pharmaceutical Inc 2.960% -1.744% -5.056% 60.952% 23.358% 81.720% -
Gilead Sciences Inc -0.610% -1.130% -5.582% -15.468% -17.410% 10.422% 2.425%
G1 Therapeutics 39.170% 17.234% -5.786% 56.075% 50.400% -75.584% -
Aldeyra Therapeutics Inc. -0.590% 2.354% -6.129% -60.899% 16.472% - -
Insmed Inc. - 3.448% -6.250% 40.351% -16.084% -9.091% -4.705%
Chimerix Inc. 0.970% 6.555% -6.387% -12.567% 6.505% -86.637% -62.905%
Xeris Biopharma Holdings Inc. -0.230% 7.514% -6.780% -19.266% -18.519% -34.230% -
Akebia Therapeutics Inc. -10.390% 10.459% -6.882% 35.454% 10.836% -49.258% -
Pacira Pharmaceuticals 0.830% -0.826% -6.977% -36.508% -19.463% -53.398% -40.887%
Vericel Corp. 1.390% 0.465% -7.296% 44.966% 33.333% 0.000% 170.236%
Organovo Holdings Inc. -6.110% -11.423% -7.338% -49.773% -13.840% -85.626% -95.105%
Eagle Pharmaceuticals Inc 1.810% 15.625% -7.500% -83.308% -0.893% -87.386% -91.589%
Intellia Therapeutics Inc 4.950% 6.833% -8.148% -45.455% -26.010% -61.558% 44.779%
Chromadex Corp -1.120% 10.559% -8.247% 187.097% 165.672% -42.581% -
Kala Pharmaceuticals Inc. -0.720% 0.080% -9.124% -54.529% -3.758% -97.182% -